Mark Currie

(Dr. Mark Currie Ph.D.)

Positions

Position Company Period
Senior Vice President, Chief Scientific Officer, President - Research and Development Ironwood Pharmaceuticals Inc Jan. 1, 2002 - April 1, 2019
Mark Currie's trades of Ironwood Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-08-15 2022-08-11 S Sale
70,000 -11.8%
11.78
USD 824,600
70,000 -11.8% 11.78 USD 824,600
2022-06-09 2022-06-07 PS Planned sale
190,383 -24.3%
12.01
USD 2,286,500
190,383 -24.3% 12.01 USD 2,286,500
2020-12-30 2020-12-28 S Sale
20,107 -7.4%
3.01
USD 60,522
20,107 -7.4% 3.01 USD 60,522
2020-01-24 2020-01-23 PS Planned sale
60,000 -9.8%
12.59
USD 755,400
60,000 -9.8% 12.59 USD 755,400
2020-01-21 2020-01-16 PS Planned sale
8,888 -1.6%
12.80
USD 113,766
8,888 -1.6% 12.80 USD 113,766
2019-12-31 2019-12-30 S Sale
25,000 -8.4%
2.48
USD 62,000
25,000 -8.4% 2.48 USD 62,000
2019-05-14 2019-05-10 PS Planned sale
4,055 -0.8%
10.53
USD 42,699
4,055 -0.8% 10.53 USD 42,699
2019-04-03 2019-04-02 B Purchase
270,107 +523.0%
14.81
USD 4,000,285
270,107 +523.0% 14.81 USD 4,000,285
2019-03-08 2019-03-08 S Sale
49,500 -8.6%
13.15
USD 650,925
49,500 -8.6% 13.15 USD 650,925
2019-03-08 2019-03-07 S Sale
225,500 -28.1%
13.29
USD 2,996,895
225,500 -28.1% 13.29 USD 2,996,895
2019-02-22 2019-02-21 PS Planned sale
13 -0.0%
14.32
USD 186
13 -0.0% 14.32 USD 186
2019-02-22 2019-02-20 PS Planned sale
1,631 -0.2%
14.31
USD 23,340
1,631 -0.2% 14.31 USD 23,340
2018-02-22 2018-02-21 PS Planned sale
1,634 -8.3%
14.66
USD 23,954
1,634 -8.3% 14.66 USD 23,954
// ... existing code ... // ... rest of the file ...